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The development of antibiotic-resistant bacteria is a worldwide health-related emergency that calls 19 
for new tools to study the bacterial metabolism and to obtain fast diagnoses. Indeed, the 20 
conventional analysis timescale is too long and affects our ability to fight infections. Slowly 21 
growing bacteria represent a bigger challenge, since their analysis may require up to months. 22 
Among these bacteria, Mycobacterium tuberculosis, the causative agent of tuberculosis has caused, 23 
only in 2016 more than 10 million new cases and 1.7 million deaths. We employed a particularly 24 
powerful nanomechanical oscillator, the nanomotion sensor, to characterize rapidly and in real time 25 
a tuberculous and a non-tuberculous bacterial species, Bacillus Calmette-Guérin and 26 
Mycobacterium abscessus exposed to different antibiotics.  27 
Here, we show how high speed and high sensitivity detectors, the nanomotion sensors, can provide 28 
a rapid and reliable analysis of different mycobacterial species, obtaining qualitative and 29 
quantitative information on their response to different drugs. 30 
This is the first application of the technique to tackle the urgent medical issue of mycobacterial 31 
infections, evaluating the dynamic response of bacteria to different antimicrobial families and the 32 
role of the replication rate in the resulting nanomotion pattern. In addition to a fast analysis, which 33 
could massively benefit patients and the overall healthcare system, we investigated the real-time 34 
response of the bacteria to extract unique information on the bacterial mechanisms triggered in 35 
response to the antibacterial pressure, with consequences both at the clinical and at the 36 
microbiological level.  37 
 38 
 39 
  40 
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Providing fast and reliable antibiotic susceptibility data, which allows initiating prompt and 42 
appropriate therapy schedules, is a main task of the clinical laboratory. While molecular techniques 43 
(i.e. MALDI-TOF Mass Spectrometry (MS) or PCR-based gene amplification)(1, 2) have radically 44 
changed the time-frame for Gram positive (+) and negative (-) bacterial identification (ID), most of 45 
current methods for antimicrobial susceptibility testing (AST) are still based on fluorescence 46 
staining or phenotypic assays(1, 3) which may require days, or even weeks, depending on the 47 
bacterial species. In conventional clinical workflow, the sample (e.g. blood, spinal fluid, urine, 48 
feces, nasal or throat swabs) is harvested from patients, streaked on agar nutrient media and, after 49 
12-24 hours incubation, transferred for further analysis. This unavoidable culture step results in 50 




 Colony Forming Units 51 
(CFU)/ml.(4) ID and culture-based AST are performed after this incubation time, and can last more 52 
than 24 hours.(5) Similar protocols are commonly used for slowly growing bacteria such as 53 
mycobacteria but, in these cases, the incubation time can be longer than a week (e.g. in the MGIT 54 
960 system), and more than one month may be required to obtain ID and AST.(5) This long 55 
timeframe, under the pressure of life-threatening infections, often results in imprudent use or misuse 56 
of antibiotics. Early appropriate therapy will significantly reduce the spread of pathogenic bacteria 57 
into the population. This will lead to higher patient survival rate, lower distress and an optimized 58 
use of the limited resources of healthcare systems.(6, 7)  59 
Many options are emerging to achieve a rapid, accurate and cost-effective pathogen characterization 60 
of bacterial response to drugs, ranging from molecular to rapid phenotypic techniques to plasmonic 61 
single cell assays.(8-11) The conventional AST molecular techniques rely mainly on the 62 
determination of the genetic fingerprint associated with resistance to a specific antibiotic, including 63 
real-time PCR (RT PCR), DNA microarrays, Next-generation sequencing (NGS), cell lysis-based 64 
approaches, whole-genome sequencing, and MALDI-TOF MS.(12-16) Even though the 65 
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aforementioned techniques can provide fast and high-throughput results, they still present profound 66 
drawbacks. For instance, their outcome is strongly dependent on specific drug-target genes, which 67 
can only be indicative of the actual antibiotic resistance, leaving a large gap for drug phenotypic 68 
response.  69 
Novel single-cell techniques are have gained importance in the last decade in particular for cancer-70 
related applications. Nevertheless, the analysis of bacterial susceptibility requires the concurrent 71 
evaluation of hundreds or thousands of bacteria to assess response at the population level. Thus, 72 
their application is mostly limited to the research laboratory and their low throughput hinders their 73 
transition to a clinical susceptibility test. 74 
Most commercial phenotypic assays rely on bacterial replication to deliver a correct AST and the 75 
timescale for antibiogram determination may range from days, for rapidly replicating bacteria, to 76 
weeks or months, for slowly growing and fastidious germs. To shorten turnaround times and costs, 77 
several automated systems are now available, including, for instance, MicroScan WalkAway 78 
(Beckman Coulter), BD Phoenix (Dickinson Becton), Vitek-2 (bioMérieux), SIDECAR 79 
(Alifax).(17, 18) The outcome is a relatively rapid susceptible/resistant response, which is available 80 
to the clinician as soon as the second day from the first examination of the sample, with large 81 
advantages for treatment, but still too long for severe infections (e.g. meningitis, sepsis). (1, 3) In 82 
addition, most of these techniques provide no clue on the particular drug effect or on the counter 83 
mechanisms employed by bacteria to react to antibiotic compounds.  84 
Among the alternatives to conventional microbiological assays, small and extremely sensitive 85 
nanomechanical oscillators(19) stand out as very promising candidates(8, 9, 20, 21). At first, such 86 
devices were employed in Atomic Force Microscopes (AFM) to study dynamic behaviour in 87 
cells(22) or proteins.(23, 24) Nowadays they are increasingly used for the detection of very small 88 
masses(25) or for nano-stress sensing in molecular biology(26) and their sensitivity and versatility 89 
 on M








is exploited in lab-on-a-chip devices to measure bio-molecular interactions(27) or mass 90 
variations in biological systems, including bacteria.(28, 29) Two major factors limit most of the 91 
available nanomechanical systems: (i) they require air or vacuum conditions for the measurements; 92 
(ii) they need bacteria to replicate directly on the sensors, to determine cell viability through mass 93 
change or local stress alterations. This reflects on the time required to perform analysis, and on the 94 
range of information that can be obtained, based on life or death assessments.  95 
Very recently, we have introduced a new way of exploiting the capabilities of cantilever 96 
nanosensors: the nanomotion sensor (NMS)(30, 31). By exploiting the intimate link between life 97 
and motion, measuring the fluctuations of flexible cantilevers that act as solid support for 98 
microorganisms, we can monitor in real time the metabolism of living organisms.(32) The sensor’s 99 
fluctuations strongly depend on the microorganisms’ metabolic activities, which combine energy 100 
consumption, cell vibration and movement. The sensitivity of the technique allows detecting the 101 
energy consumption of few ATP molecules, as demonstrated in previous works using Finite 102 
Elements Modelling or studying conformational changes in quaternary protein structures. (31, 33) 103 
Thus, the NMS can been used to evaluate the fluctuations of a very limited number of viable 104 
specimens (single mammalian cells or tens of bacteria).(32, 34-37)  105 
By measuring the fluctuations as a function of time and of external conditions, the NMS delivers a 106 
unique insight on microorganisms response to environmental, chemical or physical stimuli.(32) The 107 
amplitude and the low frequency of these fluctuations (<1 kHz) help circumventing the major 108 
limitations of current nanomechanical sensors: the NMS can be used under various conditions (i.e. 109 
buffer solutions or growing media), and the viable specimens are attached on both sides of the 110 
sensor, reducing complexity and cost of each experiment. In addition, due to the time resolution of 111 
the NMS, these experiments allow investigating in real-time and with sensitivity in the Angstrom-112 
to-micron range(33) the evolving metabolism of the adsorbed bacteria, long before a single 113 
replication(30, 31), suggesting that the analysis timescales are only marginally dependent on 114 
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bacterial duplication rates, as demonstrated by studying B. pertussis, which replicates in 48 hours 115 
(38). In addition, the sensitivity of these sensors allows extracting a measurable signal from groups 116 
of less than 100 bacterial cells, leading to a drastic reduction of incubation times. Overall, the 117 
outcome is a quantitative evaluation of the real bacterial response to the applied stimuli, on a time-118 
scale (hours) comparable to the fastest molecular analyses.(39) Furthermore, the real-time 119 
monitoring of a nanomotion susceptibility test (N-AST) reveals a different kind of information on 120 
the bacterial behaviour compared to conventional phenotypic and genetic studies, with the potential 121 
to improve therapeutic interventions, which are paramount for clinical decisions and, hopefully, 122 
therapeutic outcomes, as demonstrated in previous works on rapidly growing bacteria.(40) For this 123 
reason, coupling the NMS with other conventional techniques could help to better unravel which 124 
molecular processes arise to account for specific observed motion-change behaviour. 125 
 126 
Results  127 
We exploited the capabilities of the NMS to study slowly growing Mycobacterium bovis bacillus 128 
Calmette-Guérin (BCG) and the fast growing nontuberculous mycobacterium (NTM) 129 
Mycobacterium abscessus.(41) In particular, the former species belongs to the M. tuberculosis 130 
complex (MTC), which includes M. tuberculosis (Mtb), M. africanum, representing a growing 131 
medical emergency in both developing and developed regions.(42) By studying their nanomotion, 132 
we characterized the interaction between these two species and three antibacterial drugs, and were 133 
able to determine in a matter of hours their susceptibility, calculating their minimum inhibitory 134 
concentration (MIC) and minimum bactericidal concentrations (MBC). Furthermore, we exploited 135 
the real-time analysis of the NMS to evaluate the peculiar responses of these bacteria to the 136 
different antibacterial agents. We chose to work with a relatively large number of bacteria on the 137 
sensor (approximately between 100 and 1000 cells) to ensure a good population-level analysis of 138 
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the susceptibility and to average out the possible presence of outliers or single naturally resistant 139 
microorganisms. 140 
In preliminary experiments, we determined whether NMS preparation protocols influenced the 141 
viability of BCG and M. abscessus in the MGIT medium. Overall, we kept the bacteria for at least 142 
200 min in the analysis chamber by monitoring the oscillations over time. As shown in Figure 1, the 143 
variance of the nanomotion signals remained constant over time, indicating that the bacteria were 144 
viable for the entire control experiment.  145 
BCG 146 
We performed a series of experiments involving exposure of BCG to RIF or INH, two first line 147 
anti-TB drugs inhibiting the DNA-dependent RNA polymerase, and specific enzymes implicated in 148 
cell wall synthesis, respectively.(42, 43) We selected this species because it belongs to the MTC, is 149 
not dangerous for humans, and can be safely handled in a Biosafety Level 2 laboratory, constituting 150 
a safe NMS testing ground for the study of more dangerous mycobacteria, including Mtb.  151 
When exposed to bactericidal doses of these agents, the BCG produced a sharp reduction of the 152 
sensor’s fluctuations, underlining the drug’s activity. In a typical experiment, the outcome of the 153 
exposure to a bactericidal dose of INH (2 g/ml) could be determined in less than 30 min (Figure 154 
2). On the other hand, after exposure to a high dose of RIF (0.7 g/ml in Figure 3), we observed a 155 
reduction in the sensor’s movement, demonstrating a slower bactericidal effect and confirming 156 
bacterial death which required almost 2 hours.  157 
The subsequent step in the analysis of the response of BCG to these antibacterial agents consisted in 158 
a series of dose-dependence experiments. The results, summarized in Figure 4a for INH and 4b for 159 
RIF, indicate for each experiment the relative reduction of the nanomotion fluctuations. In both 160 
cases, the linear fit of the sigmoid curve was used to determine the MIC and MBC values. The 161 
 on M








obtained values were MIC 0.09+-0.03 g/ml and MBC 0.17+-0.03 g/ml for INH; MIC 0.15+-0.07 162 
g/ml and MBC 0.4+-0.07 g/ml for RIF. The MICs of BCG Pasteur determined by NMS differed 163 
by about 1-fold dilution from those determined by conventional proportion methods (0.2 versus 164 
0.09 g/ml for INH, and 0.063 versus 0.15 g/ml for RIF, respectively).(44-46) Such discrepancy 165 
between the conventionally measured MIC and the N-AST is something that has been also 166 
highlighted in previous experiments involving rapidly growing bacteria.(31, 39) This difference can 167 
be interpreted by invoking many factors, such as growth conditions, measurement geometry or 168 
temperature. It must be noted that conventional and NMS assays monitor different metabolic 169 
parameters. In most conventional analyses, the MIC is identified by the bacterial ability to replicate, 170 
while for the NMS, this concentration is associated to the reduction of the sensor’s fluctuations 171 
associated to alterations in the bacterial membrane elasticity(36, 37) or to their internal metabolic 172 
activity. Indeed, while the information content is the similar, the concentration at which one or the 173 
other phenomenon occurs can be different. 174 
In addition to these quantitative susceptibility results, performing a real-time analysis on antibiotics 175 
susceptibility allowed us to evaluate how the drug pressure influenced the investigated 176 
microorganisms, including their peculiar response patterns and typical timescales. For instance, 177 
INH exposure, even if using sub-MIC concentrations, caused an immediate response of BCG, 178 
which was registered as a fluctuation intensity increase that lasted 10-15 min before a rapid decay 179 
of the movements. After few tens of minutes, if the concentration was not bactericidal (i.e. 0.025 180 
g/ml in Figure 5a), the variance of the fluctuations recovered their intensity and, returned to values 181 
comparable to those measured before the antibiotic injection. This entire response pattern did not 182 
last more than 20 minutes. On the other hand, if the drug concentration was higher than the MBC 183 
(e.g. 1 g/ml, Figure 6), the response was more complex. After an initial rise of the oscillations, the 184 
movements rapidly decreased to lower values for up to 25 min, followed by few seconds of wide 185 
fluctuations. This biphasic pattern repeated itself several times for more than 1 h, until the 186 
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fluctuations stabilized to low values, indicating the death of the BCG. A possible interpretation of 187 
this pattern is related to BCG clumping: these bacteria exploit their waxy coating to form cell 188 
aggregates not completely dissolved during sample preparation procedures. In such clumps, 189 
external bacteria are expected to be metabolically more active than internal ones, partially shielding 190 
them from some environmental attacks. In this view, the bactericidal antibiotics could kill, at first, 191 
the cells of the external layer, and then the internal bacteria would be activated, resulting in the 192 
movement-stasis pattern we observed and measured. Clumping is an already known defense 193 
mechanism in microbiology and can be found in many different species, such as Candida albicans, 194 
or in self-aggregation in Escherichia coli or in flocculation in Saccharomyces cerevisiae (47-50) but 195 
it has never been reported in this way for BCG. 196 
While we identified these peculiar movements in INH-exposed BCG, these were never seen in RIF 197 
experiments (Figure 5b), suggesting that this behavior is strictly dependent on the response 198 
mechanism of BCG to INH. Indeed, the response against 0.07 g/ml of RIF did not involve a strong 199 
initial reaction to the drug, with fluctuations lasting from 1 to 2 h. In some cases, after minutes from 200 
drug exposure, we measured a temporary reduction of movements, which lasted up to 30 min, 201 
followed by full recovery of the nanomotion fluctuations. Furthermore, in RIF-exposed BCG, we 202 
never identified the oscillating patterns seen for INH. A possible interpretation of the different 203 
reported behavior respect to the two different drugs could rely on their different time-scale of the 204 
effect. While INH affects the cell wall synthesis, its effect is quite fast and the shielding of the 205 
clumping could produce a visible transitional oscillation. On the other hand, since RIF targets RNA 206 
polymerase consequently blocking protein translation, its longer timescale could cover the 207 
aforementioned effect. 208 
M. abscessus 209 
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To investigate the response of drugs against M. abscessus, we used the protein synthesis inhibitor, 210 
amikacin (AK), because this organism is known to be resistant to INH and RIF. In the presence of a 211 
bactericidal concentration of the drug (10 g/ml in Figure 7a), M. abscessus did not show an 212 
immediate response, without alterations of the fluctuations for the first 30 min, followed by a sharp 213 
decrease of the movements between 50 and 70 minutes, after which the fluctuations did not recover. 214 
When non-bactericidal doses were used (1 g/ml in Figure 7b), a lag phase of approximately 10-25 215 
min was observed, followed by a full recovery of the nanomotion signal. This trend is in line with 216 
the NMS response of Staphylococcus aureus exposed to cefoxitin(31) or E. coli to ceftriaxone(39). 217 
It is worth noting that the response time of M. abscessus to AK (50-70 minutes) is longer than in the 218 
BCG-INH case (20-30 min) and comparable with the BCG-RIF timescales (80-100 min). This can 219 
be attributed to the different mechanisms of action of AK compared to INH. Indeed, INH inhibits 220 
the cell wall synthesis and is expected to have a more rapid effect than RIF and AK, which inhibit 221 
the protein synthesis. Remarkably, the response times of the BCG and M. abscessus are similar to 222 
the typical timescales of the experiments involving rapidly replicating bacteria (between 15 and 60 223 
minutes for both E. coli and S. aureus(31, 39)). This clearly demonstrates the nanomotion sensor’s 224 
independence to the replication rate of the specimens under investigation. Furthermore, it also 225 
depicts the range of interesting new information that the technique can provide. 226 
As done for BCG, we performed a series of dose-dependence measurements, in order to obtain 227 
quantitative susceptibility results for M. abscessus exposed to AK (Figure 4c). The linear fit for the 228 
sigmoid curve indicated a MIC of 1.7+-0.6 g/ml and a MBC of 7.8+-0.6 g/ml. These 229 
concentrations are in good agreement (within one dilution) with those present in literature for this 230 












M. tuberculosis and NTM are the causative agents of extremely dangerous infections, such as TB, 234 
which caused in 2016 more than 10.4 million new cases and 1.7 million deaths in developing and 235 
industrialized countries (WHO Global TB Report 2017). A fast diagnosis of these bacteria will 236 
allow a more specific, tailored treatment, more effective, better tolerated by the patient, and less 237 
likely to produce relapses. An early diagnosis of infections from slowly growing bacteria could be 238 
lifesaving and could significantly reduce the spread of harmful pathogens into the population, 239 
leading to higher survival rate, lower distress and an improved use of the limited resources of the 240 
healthcare system.(53, 54) 241 
This work shows how the NMS can be used to obtain a rapid and reliable investigation of the MTC 242 
and NTM, with possible impact in the early clinical and diagnostics fields. Indeed, while the clinical 243 
application of the NMS has already been demonstrated on E. coli,(39) its importance to the study of 244 
slowly growing germs can be safely suggested. In addition, the speed of the nanomotion analyses 245 
can allow a rapid screening of innovative molecules and antitubercular agents, to accelerate and 246 
reduce the costs for drug discovery and drug development.(55, 56) Furthermore, the NMS can 247 
highlight the specific behavior of slowly growing bacteria during antibiotic treatment, evidencing 248 
cooperative vibrations and activity reduction, which could not be determined using other 249 
phenotypic techniques. This provides a better overview of the metabolism of slowly growing 250 
bacteria in models more closely mimicking in vivo microenvironments and of their dynamic 251 
responses to external stimuli, which is of great importance in medical and pharmacological TB 252 
research. These results illustrate how N-AST can become a reliable and rapid investigation tool for 253 
slowly growing bacterial species, providing also a new insight into the behavior of these bacteria 254 
during antibiotic treatment. 255 
The possibility to combine NMS and molecular biology assays would deliver a thorough 256 
comprehension of the bacterial resistance mechanisms, which could provide invaluable information 257 
 on M








to produce newer, more targeted drugs and anti-mycobacterial agents, to fight some of the deadlier 258 
diseases of our times. 259 
 260 
Materials and methods 261 
Substrates, enzymes and reagents  262 
Chemicals, phosphate buffered saline (PBS), glutaraldehyde and antibiotics rifampicin (RIF), 263 
isoniazid (INH) and amikacin (AK), all with analytical grade, were obtained from Sigma-Aldrich 264 
(St Louis, MO). MGIT 960 (MGIT) tubes (Becton-Dickinson Microbiology Systems, Sparks, MD) 265 
were used to obtain the bacterial culture medium.  266 
 267 
Bacterial preparation and isolation 268 
Mycobacterium bovis BCG [American Type Culture Collection (ATCC) 27291 (Pasteur strain)] 269 
cells, frozen at -70°C, were thawed, and grown in Löwenstein Jensen slants at 37°C for 3 weeks. 270 
Few colonies were transferred in tubes containing 500 l of MGIT medium. Since the BCG tends to 271 
form clumps that are difficult to disaggregate, before transferring the bacteria-rich medium to the 272 
nanomotion experiments we vortexed the tubes to ensure that any large bacterial clump was 273 
dissolved or reduced. Still, as shown in Figure 8, small BCG clumps were present on the sensors. 274 
The MIC of BCG Pasteur was determined using the proportion method. The characterizations 275 
showed that, in good agreement with the values present in literature, the MICs were 0.2 g/ml for 276 
INH(45) and 0.063 g/ml for RIF(46), respectively, with an uncertainty of one dilution. 277 
Mycobacterium abscessus [ATCC 19977] cells frozen at -70°C were thawed, and the specimens 278 
were grown in MGIT medium at 37°C for 3 days under continuous agitation. 1 ml of the bacteria-279 
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rich medium was centrifuged (5000 rpm for 5 min), the pellet was re-suspended in PBS and 280 
transferred directly to nanomotion experiments. The susceptibility values present in literature for 281 
ATCC 19977 towards amikacin detail a MIC of 3.1 g/ml, with an uncertainty of one dilution.(52) 282 
 283 
Nanomotion experiments 284 
The nanoscale movements of the microorganisms induced dynamic deflections of the NMS, which 285 
we monitored in real-time, using the laser-based signal transduction typically used in most AFMs. 286 
We collected these fluctuations in a time-dependent chart of the vertical movements of the sensor, 287 
which appeared as a coloured noise signal, superposition of a large number of vibrations.. Overall, a 288 
typical experiment lasted more than 2 hours divided in data chunks of at least 30 minutes. The 289 
control experiments were carried out for at least 4 hours. In each experiment, the sensors were 290 
followed in real-time using optical cameras. 291 
We used a commercial Nanowizard III microscope (JPK Instruments, Berlin, DE) and custom 292 
homemade devices developed in the Laboratories of Living Matter Physics at the EPFL (LPMV-293 
EPFL). The sensors chosen for the JPK experiments were the ONP-10 tipless AFM cantilevers from 294 
Bruker (Bruker Nano Inc., MA, USA). For the homemade devices, we employed the SD-qp-CONT 295 
tipless cantilevers (Nano and More Gmbh, DE). For all experiments, we used sensors with spring 296 
constant in the range of 0.08+-0.03 N/m, which demonstrated a good sensitivity coupled with 297 
geometrical properties that ensured space for an adequate number of bacteria (as controlled through 298 
optical images throughout each experiment). The data from the Nanowizard III microscope were 299 
collected using the JPK software using a 10 kHz acquisition rate, while the data from the 300 
experiments on the custom devices were collected using a USB-4431 DAQ card (National 301 
Instruments, USA), using a 20 kHz acquisition rate. Remarkably, as a demonstration of the solidity 302 
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of the analysis technique, we were able to compare the results obtained with the two different 303 
instrumentations, which exhibited similar sensitivity and noise levels.  304 
To enhance bacterial adhesion, as established and detailed in many previous works, we chemically 305 
treated the sensors. In literature, there are examples of fibronectin, poly-lysine, polyethylene imine, 306 
APTES, glutaraldehyde, concanavalin or even collagen used for this purpose.(15, 40, 57-60)  In 307 
comparison with the specimens analyzed in some previous works,(61) the thick, hydrophobic and 308 
waxy cell walls of mycobacteria required new immobilization strategies and the use of specific 309 
culture media and drugs. In the present work,  we exposed the sensors to 0.5% glutaraldehyde for 310 
15 min, followed by rinsing in ultrapure water and air-drying. This immobilization protocol allowed 311 
mycobacteria to adhere on the sensors with little influence on their metabolic activity (as 312 
demonstrated by the control experiments depicted in Figure 1) 313 
We equipped both instruments with closed custom analysis chambers, made of plastic or 314 
polydimethylsiloxane (PDMS), which allowed performing experiments in liquid while changing the 315 
medium with very low noise(62). 316 
For the subsequent immobilization of the living bacteria on the sensors, we strictly followed a 317 
protocol that ensured a remarkable adhesion of the cells on the sensors. Since the growth media 318 
often contain complex molecules that could passivate the chemical functionalization on the sensor, 319 
we washed twice in PBS an aliquot of MGIT-containing bacteria (by centrifuging cells at 3000xg 320 





CFU). In order to let the bacteria adhere on the sensor we deposited a droplet (typically 20 µl) of 322 
the bacteria-rich PBS on the sensor and incubated at room temperature for about 15 min. This 323 
protocol allows the formation of a roughly uniform distribution of bacteria on the sensor surface, 324 
with  an innate variability in their number and spatial distribution. Thereafter, we mounted the 325 
sensor on the holder and inserted it into the analysis chamber, carrying 2 ml of MGIT medium for 326 
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the analyses. As shown in the optical images of the sensors during the experiments (Figure 8), an 327 
approximate estimate of 100 to 1000 cells adhered to the NMS, while more complex procedures 328 
must be carried out to obtain a quantitative determination.(31) It is worth highlighting that the 329 
immobilization protocol produces a variability in the absolute value of the oscillations which are 330 
different for each experiment, but the strong attachment ensures that the number and position of the 331 
bacteria is well-preserved throughout each single analysis.  332 
As detailed in previous works, to generate dose-dependence curves we compared several parallel 333 
experiments in which the bacteria were exposed to different concentrations of antibiotic drugs. To 334 
obtain these graphs we focused on the relative reduction of the fluctuations compared to the 335 
maximum variance measured before the exposure to the chosen drug concentration. In this way we 336 
were able to define a comparative measure of the bacterial response and to compare and average the 337 
many experiments we have performed. Each experiment was performed at least in triplicate, lasted 338 
at least 2 hours and comprised three steps: i) preparation of viable bacteria in medium (BCG or M. 339 
abscessus in MGIT medium); ii) exposure to the desired drug concentration (INH, RIF or AK); iii) 340 
exposure to a high bactericidal drug concentration.(31) The concentration dependence curve was 341 
then fitted with a sigmoid curve interpolation, bearing a similar information content of a 342 
conventional antibiogram. By performing a linear fitting of the central part of the sigmoid, we 343 
calculated two concentration values which can be associated to the minimum inhibitory 344 
concentration (MIC - the drug concentration that inhibits visible bacterial growth) and the minimum 345 
bactericidal concentration (MBC - the concentration that ensures the death of 99.9% of the 346 
bacteria)(31). New AST assays, intended as substitute of conventional microbiological procedures 347 
should provide these two concentrations, and this is one of the main advantages of phenotypic 348 
assays compared to faster molecular counterparts. Indeed, just as for the conventional values, at 349 
drug concentrations below the NM-MIC, the fluctuations of the cantilever are largely unaffected, 350 
while at values higher than the NM-MBC the movements are largely reduced.  351 
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Statistical analysis 353 
The nanomotion data is presented as acquired, with a simple linear fit to remove any long-term drift 354 
from the traces. The variance calculations are presented as histograms +-SD calculated on the 355 
corresponding fluctuations over the corresponding raw data, but the trends are indicative of at least 356 
three independent sample preparations.  357 
Each datapoint of the dose-dependence graphs was obtained from minimally three independent 358 
experiments and the graphs were drawn following the procedures detailed elsewhere.(31) The error 359 
bars represent the variability of the different experiments performed at each concentration.  360 
  361 
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Figure captions 566 
 567 
Figure 1. Control experiments involving BCG and M. abscessus. Typical data patterns 568 
(performed minimally in triplicate) of BCG (panel a) and M. abscessus (panel b) in MGIT medium. 569 
The fluctuations are present for more than 200 minutes. 570 
 571 
Figure 2. Nanomotion experiments on BCG exposed to an over-MIC dose of INH. Top panel. 572 
Typical 10 minutes segments of the sensor’s fluctuations: before the exposure to INH (left); 573 
immediately after the exposure to INH at 2 g/ml (center); 20 minutes after the exposure to INH, 574 
when the movement reduction has stabilized. Lower panel. Histogram of the corresponding 575 
variance of the fluctuations. The graph is representative of minimally 5 independent experiments 576 
which produced similar results. The error bars in the variance histogram represent +- SD of the 577 
corresponding fluctuations over the shown 10-minute time-period. 578 
 579 
Figure 3. Nanomotion experiments on BCG exposed to an over-MIC dose of RIF. Top panel. 580 
Typical 20 minutes segments of the sensor’s fluctuations: before the exposure to RIF (left); 581 
immediately after the exposure to RIF at 0.7 g/ml (center); 80 minutes after the exposure to RIF, 582 
when the movement reduction has stabilized. Lower panel. Histogram of the corresponding 583 
variance of the fluctuations. The graph is representative of 3 independent experiments which 584 
produced similar results. The error bars in the variance histogram represent +- SD of the 585 
corresponding fluctuations over the shown 20-minute time-period.  586 
  587 
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Figure 4. Dose dependence experiments. Panel a. Normalized variance calculated from the 588 
deflections collected by exposing the BCG to different INH concentrations. Panel b. Normalized 589 
variance calculated from the deflections collected by exposing the BCG to different RIF 590 
concentrations. Panel c. Normalized variance calculated from the deflections collected by exposing 591 
the M. abscessus to different AK concentrations. The concentration values can be well fitted with a 592 
sigmoid function, which is comparable with the antibiogram plots, obtained using conventional 593 
microbiological techniques. The MIC and the MBC of towards the bacterial species can be obtained 594 
by calculating the tangent of the sigmoid fit at half height (black dashed line). Each data-point 595 
represents the average of a minimum of 3 independent experiments performed using the same drug 596 
concentration. The error bars represent the variability of the different experiments performed at the 597 
same concentration. In each graph, the experiments involving sub-MIC drug concentrations are 598 
represented as a single data-point, which summarizes all these experiments. 599 
 600 
Figure 5. Nanomotion experiments on BCG exposed to a sub-MIC dose of INH and RIF. Panel 601 
a: Top panel. Typical 20 minutes segments of the sensor’s fluctuations: before the exposure to INH 602 
(left); immediately after the exposure to INH at 0.025 g/ml (center); 140 minutes after the 603 
exposure to INH, when the movement has stabilized. Lower panel. Histogram of the corresponding 604 
variance of the fluctuations. Panel b: Top panel. Typical 20 minutes segments of the sensor’s 605 
fluctuations: before the exposure to RIF (left); immediately after the exposure to RIF at 0.07 g/ml 606 
(centre); 95 minutes after the exposure to RIF, when the movement has stabilized. Lower panel. 607 
Histogram of the corresponding variance of the fluctuations. Each graph is representative of 608 
minimally 3 independent experiments which produced similar results. The error bars in the variance 609 
histogram represent +- SD of the corresponding fluctuations over the shown 20-minute time-period.  610 
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Figure 6. Time-resolved analysis of the BCG response to INH. Typical data pattern of the 611 
response of BCG to a bactericidal dose of INH (1 g/ml). Over a 140-minute period, the 612 
fluctuations increase and decrease in amplitude, highlighting the bacterial response to the antibiotic 613 
pressure. The graph is representative of 3 independent experiments in which this feature was 614 
evidenced.  615 
 616 
Figure 7. Nanomotion experiments on M. abscessus exposed to AK. Panel a: Top panel. Typical 617 
20 minutes segments of the sensor’s fluctuations exposed to an over-MIC dose of AK: before the 618 
exposure to AK (left); immediately after the exposure to AK at 10 g/ml (center); 50 minutes after 619 
the exposure to AK, when the movement has stabilized. Lower panel. Histogram of the 620 
corresponding variance of the fluctuations. Panel b: Top panel. Typical 20 minutes segments of the 621 
sensor’s fluctuations exposed to a sub-MIC dose of AK: before the exposure to AK (left); 30 622 
minutes after the exposure to AK at 1 g/ml (center); 90 minutes after the exposure to AK, when 623 
the movement has recovered and stabilized. Lower panel. Histogram of the corresponding variance 624 
of the fluctuations. Each graph is representative of at least 3 independent experiments which 625 
produced similar results. The error bars in the variance histogram represent +- SD of the 626 
corresponding fluctuations over the shown 20-minute time-period.  627 
  628 
 on M








Figure 8. Optical images of bacteria-bearing sensors. Typical optical images of rectangular (left 629 
panels) and triangular sensors (right panels) bearing BCG (panel a) and M. abscessus (panel b). The 630 
optical images show the BCG clumping. The scale bars indicate 50 m. 631 
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